Breaking News Instant updates and real-time market news.

DVAX

Dynavax

$12.95

-0.05 (-0.38%)

16:14
08/06/18
08/06
16:14
08/06/18
16:14

Dynavax reports Q2 EPS (63c), consensus (62c)

Reports Q2 revenue $1.25M, consensus $1.62M.

  • 06

    Aug

DVAX Dynavax
$12.95

-0.05 (-0.38%)

04/17/18
WBLR
04/17/18
NO CHANGE
WBLR
Outperform
William Blair says SD-101 not in $40 fair estimate for Dynavax shares
Dynavax Technologies' data thus far in squamous cell carcinoma of the head and neck and melanoma are "compelling" and will see SD-101 "finally getting into" the stock as the Street comes to appreciate the oncology side of the business, William Blair analyst Y. Katherine Xu tells investors in a research note. She points out that SD-101, or Dynavax's other oncology assets, are not included in her $40 fair value estimate of the stock. These opportunities represent "significant upside to our valuation," Xu contends. The analyst keeps an Outperform rating on Dynavax. The stock closed yesterday at $18.85.
05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
Dynavax upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Dynavax Technologies to Overweight and raised his price target for the shares to $27 from $25 following the company's Q1 results. The analyst believes TLR9 agonist SD-101 is an underappreciated asset.
05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
JPMorgan upgrades Dynavax on 'vastly underappreciated' SD-101
JPMorgan analyst Anupam Rama upgraded Dynavax Technologies to Overweight from Neutral and raised his price target for the shares to $27 from $25. While a Heplisav launch inflection in 2019 is widely expected, the company's SD-101 opportunity is being "vastly underappreciated" at current share levels, Rama tells investors in a research note. SD-101 has shown encouraging early signals of efficacy in both the melanoma and head and neck indications, the analyst contends. Rama points out that a Phase 2 melanoma update is expected next month at ASCO. He likes the stocks' reward/risk profile going into the readout. The analyst sees 30%-60% upside potential versus 0%-10% downside risk on the data.
05/17/18
JPMS
05/17/18
NO CHANGE
JPMS
Overweight
Dynavax should trade to $21-$22 on abstract data, says JPMorgan
JPMorgan analyst Anupam Rama believes shares of Dynavax should trade up 5%-15% to the $21-$22 range on the SD-101 melanoma ASCO abstract. While some on the Street were inappropriately setting the benchmark at 70%-80% overall response, the abstract data "very much put the early efficacy signals" of SD-101 plus pembrolizumab in the ballpark of nivolumab plus ipilimumab from CHECKMATE-067, with a cleaner safety profile, Rama tells investors in a research note. He says the abstract met his "base case / win / upside scenario."

TODAY'S FREE FLY STORIES

AGO

Assured Guaranty

$45.19

-0.14 (-0.31%)

14:07
03/22/19
03/22
14:07
03/22/19
14:07
Conference/Events
Assured Guaranty management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 16

    Apr

  • 17

    Apr

14:03
03/22/19
03/22
14:03
03/22/19
14:03
General news
Treasury Budget data reported »

February Treasury Budget…

QCOM

Qualcomm

$57.16

-0.6 (-1.04%)

14:00
03/22/19
03/22
14:00
03/22/19
14:00
Options
Size spread in Qualcomm as shares slip »

Size spread in Qualcomm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

EVER

EverQuote

$7.80

-0.1 (-1.27%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
EverQuote management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

RYTM

Rhythm Pharmaceuticals

$30.01

-0.64 (-2.09%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
Rhythm Pharmaceuticals management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TWOU

2U

$66.19

-2.92 (-4.23%)

13:57
03/22/19
03/22
13:57
03/22/19
13:57
Conference/Events
2U management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

GLW

Corning

$33.89

-0.91 (-2.61%)

13:55
03/22/19
03/22
13:55
03/22/19
13:55
Options
Corning put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEC

Alphatec

$2.60

-0.12 (-4.41%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Alphatec management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

TLRA

Telaria

$6.16

-0.25 (-3.90%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

SRDX

Surmodics

$42.26

-3.67 (-7.99%)

13:51
03/22/19
03/22
13:51
03/22/19
13:51
Conference/Events
Surmodics management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

TPR

Tapestry

$31.23

-0.72 (-2.25%)

13:49
03/22/19
03/22
13:49
03/22/19
13:49
Options
Tapestry option volume 4x normal as shares test multiyear lows »

Tapestry option volume 4x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

, RHHBY

Roche

$0.00

(0.00%)

13:46
03/22/19
03/22
13:46
03/22/19
13:46
Recommendations
Ionis Pharmaceuticals, Roche analyst commentary  »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

13:45
03/22/19
03/22
13:45
03/22/19
13:45
General news
Treasury Budget to be reported at 14:00 »

February Treasury Budget…

SLCA

U.S. Silica

$15.90

-1.08 (-6.36%)

13:40
03/22/19
03/22
13:40
03/22/19
13:40
Options
6.3% drop in Silica motivates an upside call buyer »

6.3% drop in Silica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

SHOP

Shopify

$201.50

-3.48 (-1.70%)

13:39
03/22/19
03/22
13:39
03/22/19
13:39
Hot Stocks
Mailchimp asks to remove Shopify integration over new terms of service »

Mailchimp issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$139.28

-2.09 (-1.48%)

13:35
03/22/19
03/22
13:35
03/22/19
13:35
Options
IBM put volume heavy and directionally bearish »

Bearish flow noted in IBM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

PLCE

Children's Place

$86.53

-0.97 (-1.11%)

13:22
03/22/19
03/22
13:22
03/22/19
13:22
Conference/Events
Children's Place management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 02

    Apr

SPLK

Splunk

$126.05

-6.43 (-4.85%)

13:20
03/22/19
03/22
13:20
03/22/19
13:20
Options
Odd opening print in Splunk expiring contracts »

Odd opening print in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 09

    Jul

VSAT

ViaSat

$75.82

-1.15 (-1.49%)

13:18
03/22/19
03/22
13:18
03/22/19
13:18
Conference/Events
ViaSat management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TDS

Telephone and Data

$31.39

-0.47 (-1.48%)

13:17
03/22/19
03/22
13:17
03/22/19
13:17
Conference/Events
Telephone and Data management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
03/22/19
03/22
13:17
03/22/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USM

U.S. Cellular

$46.51

-0.73 (-1.55%)

13:16
03/22/19
03/22
13:16
03/22/19
13:16
Conference/Events
U.S. Cellular management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
03/22/19
03/22
13:16
03/22/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNL

Global Net Lease

$18.77

-0.33 (-1.73%)

13:16
03/22/19
03/22
13:16
03/22/19
13:16
Conference/Events
Global Net Lease management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

  • 15

    Apr

MMM

3M

$204.97

-4.62 (-2.20%)

13:15
03/22/19
03/22
13:15
03/22/19
13:15
Options
3M put volume heavy and directionally bearish »

Bearish flow noted in 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.